These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study. Bhatnagar A, Kanwar AJ, Parsad D, De D. J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845 [Abstract] [Full Text] [Related]
3. A pilot study of combined oral minocycline and narrowband UVB phototherapy in vitiligo: A randomized, double-blind, placebo-controlled trial. Charoenpongpun N, Kamanamool N, Udompataikul M, Khunkhet S, Kanokrungsee S. Dermatol Ther; 2022 Aug; 35(8):e15596. PubMed ID: 35608017 [Abstract] [Full Text] [Related]
4. Evaluation for Skin Cancer and Precancer in Patients With Vitiligo Treated With Long-term Narrowband UV-B Phototherapy. Bae JM, Ju HJ, Lee RW, Oh SH, Shin JH, Kang HY, Park JH, Kim HJ, Jeong KH, Lee HJ, Lee S, Kim DH, Lee DY, Kim YC, Choi GS, Kim KH, Park CJ, Choi CW, Korean Society of Vitiligo. JAMA Dermatol; 2020 May 01; 156(5):529-537. PubMed ID: 32159729 [Abstract] [Full Text] [Related]
5. Narrow-band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo. Arca E, Taştan HB, Erbil AH, Sezer E, Koç E, Kurumlu Z. J Dermatol; 2006 May 01; 33(5):338-43. PubMed ID: 16700666 [Abstract] [Full Text] [Related]
6. Narrow-band UVB treatment of vitiligo in Chinese. Chen GY, Hsu MM, Tai HK, Chou TC, Tseng CL, Chang HY, Lan CC, Sheu HM. J Dermatol; 2005 Oct 01; 32(10):793-800. PubMed ID: 16361730 [Abstract] [Full Text] [Related]
10. Tacalcitol: a useful adjunct to narrow-band ultraviolet-B phototherapy in vitiligo. Sahu P, Jain VK, Aggarwal K, Kaur S, Dayal S. Photodermatol Photoimmunol Photomed; 2016 Sep 01; 32(5-6):262-268. PubMed ID: 27552149 [Abstract] [Full Text] [Related]
11. Clinical study of repigmentation patterns with either narrow-band ultraviolet B (NBUVB) or 308 nm excimer laser treatment in Korean vitiligo patients. Yang YS, Cho HR, Ryou JH, Lee MH. Int J Dermatol; 2010 Mar 01; 49(3):317-23. PubMed ID: 20465673 [Abstract] [Full Text] [Related]
12. Predictive Model for Response Rate to Narrowband Ultraviolet B Phototherapy in Vitiligo: A Retrospective Cohort Study of 579 Patients. Cabrera R, Hojman L, Recule F, Sepulveda R, Delgado I. Acta Derm Venereol; 2018 Apr 16; 98(4):416-420. PubMed ID: 29362810 [Abstract] [Full Text] [Related]
13. Acceleration of melanocyte senescence by the proinflammatory cytokines IFNγ and TNFα impairs the repigmentation response of vitiligo patients to narrowband ultraviolet B (NBUVB) phototherapy. Dong BQ, Liao ZK, Le Y, Jiang S, Luo LF, Miao F, Le Poole IC, Lei TC. Mech Ageing Dev; 2023 Apr 16; 211():111779. PubMed ID: 36731753 [Abstract] [Full Text] [Related]
14. Serum levels of homocysteine, folate and vitamin B12 in patients with vitiligo before and after treatment with narrow band ultraviolet B phototherapy and in a group of controls. Ataş H, Cemil BÇ, Gönül M, Baştürk E, Çiçek E. J Photochem Photobiol B; 2015 Jul 16; 148():174-180. PubMed ID: 25941975 [Abstract] [Full Text] [Related]
15. Short-term effects of 308-nm xenon-chloride excimer laser and narrow-band ultraviolet B in the treatment of vitiligo: a comparative study. Hong SB, Park HH, Lee MH. J Korean Med Sci; 2005 Apr 16; 20(2):273-8. PubMed ID: 15832000 [Abstract] [Full Text] [Related]
16. Psoralen and narrowband UVB combination provides higher efficacy in treating vitiligo compared with narrowband UVB alone: A randomised clinical trial. Zabolinejad N, Maleki M, Salehi M, Ashrafi Z, Molkara S, Layegh P. Australas J Dermatol; 2020 Feb 16; 61(1):e65-e69. PubMed ID: 31651037 [Abstract] [Full Text] [Related]
17. The impact of positive antinuclear antibody on narrowband ultraviolet B phototherapy in patients with vitiligo: A retrospective chart review. Nahhas AF, Nartker NT, Braunberger TL, Jacobsen G, Hamzavi IH. Photodermatol Photoimmunol Photomed; 2019 Mar 16; 35(2):106-109. PubMed ID: 30267591 [Abstract] [Full Text] [Related]
18. Narrowband UVB phototherapy in vitiligo: evaluation of results in 53 patients. Percivalle S, Piccino R, Caccialanza M, Forti S. G Ital Dermatol Venereol; 2008 Feb 16; 143(1):9-14. PubMed ID: 18833047 [Abstract] [Full Text] [Related]
19. Evaluation of narrow-band UVB phototherapy in 150 patients with vitiligo. Kishan Kumar YH, Rao GR, Gopal KV, Shanti G, Rao KV. Indian J Dermatol Venereol Leprol; 2009 Feb 16; 75(2):162-6. PubMed ID: 19293504 [Abstract] [Full Text] [Related]
20. Efficacy and safety of tretinoin 0.05% cream to prevent hyperpigmentation during narrowband UV-B phototherapy in patients with facial vitiligo: a randomized clinical trial. Ju HJ, Kim SH, Lee JH, Kim GM, Bae JM. J Dermatolog Treat; 2022 May 16; 33(3):1738-1741. PubMed ID: 32869680 [Abstract] [Full Text] [Related] Page: [Next] [New Search]